Meet the 2020 Laureates: R. Michael Tuttle, MD

michaelTuttle PIC 2017

Michael Tuttle, MD

Outstanding Scholarly Physician Award

Michael Tuttle, MD, is professor of medicine, Cornell University and clinical director of the Endocrine Service, Memorial Sloan Kettering Hospital. He is a leading clinician-investigator in the field of thyroid cancer and his work has shifted the paradigm in differentiated thyroid cancer (DTC) treatment.

Dr. Tuttle is a leader in the study of radiation-induced thyroid cancer, having served as consultant to the Centers for Disease Control for Radiation Exposure of Peoples in the Marshall Islands, The Hanford Downwinder Project, and advisor to the National Academy of Science for Radiation Exposed Populations. He remains at the forefront in identifying driver mutations for DTC and exploiting these pathways with multi-kinase inhibitors (TKI) for treatment of radioiodine resistant DTC.

Dr. Tuttle…serves as a mentor to innumerable young clinicians, a leader in the Endocrine Society…and as a true role model for everyone in endocrinology. He is the penultimate clinician-scientist.

Dr. Tuttle’s work changed the way in which we manage DTC. Prior to this, all patients with DTC were treated with total thyroidectomy and radioactive iodine (RAI). Dr. Tuttle was one of the pioneers to use serum thyroglobulin (Tg) as an indicator of residual DTC. He led international studies proving the efficacy of recombinant thyrotropin (rhTSH) for determination of TSH-stimulated Tg. This work led to stratification of patients with DTC into risk categories based on operative findings, and serum Tg levels, thus allowing low-risk patients to avoid RAI and to be treated with lobectomy alone. In conjunction with his molecular studies, his clinical work opened the field for multikinase inhibitor (TKI) therapy for radio-iodine resistant DTC, an area in which he remains one of the most important pioneers.

Dr. Tuttle leads expert panels to develop treatment guidelines for DTC, and serves as a mentor to innumerable young clinicians, a leader in the Endocrine Society and the American Thyroid Association, and as a true role model for everyone in endocrinology. He is the penultimate clinician-scientist.

 

You may also like

  • Individuals Taking Class of Steroid Medications at High Risk for COVID-19

    JCEM Editors examine pandemic’s impact on endocrine patients in editorial Individuals taking a class of steroid hormones called glucocorticoids for conditions such as asthma, allergies and arthritis on a routine basis may be unable to mount a normal stress response and are at high risk if they are infected with the virus causing COVID-19, according…

  • Endocrine Society Elects Wysham as 2021-2022 President

    Five endocrinologists to join Board of Directors Endocrine Society members have elected Carol H. Wysham, MD, to serve as the organization’s President for the 2021-2022 term. Wysham is an endocrinologist at Rockwood/MultiCare Health Systems in Spokane, Wash., and Clinical Professor of Medicine at the University of Washington. She will serve as President-Elect for a year…

Find more in